Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Kidney Medicine is Scopus-indexed (Q1, CiteScore 4.8), WoS ESCI, DOAJ. Published by Elsevier Inc..
Checked against the index lists dated .
ISSN 2590-0595Verify ISSN ↗
Publisher: Elsevier Inc.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Nephrology | 21 / 88 | 76th | Q1 |
| Internal Medicine | 62 / 179 | 65th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q1, CiteScore 4.8.
Kidney Medicine is Q1 in Nephrology (rank 21 of 88) and Q2 in Internal Medicine (rank 62 of 179), by CiteScore 2025.
Kidney Medicine is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.8, which places it in quartile Q1 at the 76th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.305, quartile Q1, with an H-index of 36.
The publisher lists an article processing charge of about US$2,590 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Kidney Medicine is published by Elsevier Inc. Its ISSN is 2590-0595.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Kidney Medicine has an h-index of 46 and a 2-year mean of 1.92 citations per paper (OpenAlex). Its Scopus CiteScore is 4.8, quartile Q1. On 2-year citations it ranks #28 of 87 Scopus journals in Nephrology.
Kidney Medicine published 274 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 93 research articles (2026), authors are most often from United States (41.8%), China (8.1%) and Japan (7.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.